2.1 Dental Management of Medically Compromised Patients
Key Takeaways
- Elective invasive dental procedures must be deferred for 6 months following an acute myocardial infarction, restricting emergency care to conservative pain relief and local haemostasis.
- According to NICE Clinical Guideline CG64, routine antibiotic prophylaxis is not recommended for dental procedures to prevent infective endocarditis, prioritizing oral hygiene maintenance instead.
- For patients on Warfarin, minor oral surgery can proceed safely without interrupting anticoagulation if the INR checked within 24 hours (or up to 72 hours if stable) is 4.0 or below.
- Patients receiving daily systemic corticosteroids equivalent to prednisolone 7.5 mg or more for over 2 weeks within the preceding 3 months require hydrocortisone supplementation to prevent adrenal crisis.
- Glucagon 1 mg intramuscularly is indicated for severe hypoglycaemia (blood glucose < 4.0 mmol/L) in an unconscious diabetic patient when intravenous access or oral Glucogel cannot be administered.
2.1 Dental Management of Medically Compromised Patients
Providing dental treatment to medically compromised patients requires a thorough understanding of systemic pathology, pharmacological interactions, and emergency medical protocols. UK dental practitioners must evaluate medical histories systematically to stratify risk and tailor dental interventions accordingly.
Medical Risk Stratification & The ASA System
The ASA Physical Status Classification system, developed by the American Society of Anesthesiologists and widely adopted across UK healthcare settings, categorizes patients based on systemic disease severity:
| ASA Class | Clinical Definition | Dental Management Considerations |
|---|---|---|
| ASA I | Normal, healthy patient | Standard dental treatment without modification |
| ASA II | Mild systemic disease without functional limitation (e.g. well-controlled hypertension, well-controlled asthma) | Minimal modifications; stress reduction protocols |
| ASA III | Severe systemic disease with definite functional limitation (e.g. stable angina, poorly controlled diabetes, past MI > 6 months) | Significant modifications; limit appointment duration; consult medical GP/specialist |
| ASA IV | Severe systemic disease that is a constant threat to life (e.g. unstable angina, recent MI < 6 months, severe heart failure) | Elective dental treatment contraindicated; emergency care in hospital setting |
| ASA V | Moribund patient not expected to survive 24 hours | Emergency palliative care only |
| ASA VI | Declared brain-dead organ donor | Not applicable to outpatient dental care |
Cardiovascular Disorders in Dental Practice
Hypertension
Blood pressure (BP) screening is essential prior to invasive procedures. Elective dental treatment should proceed for patients with BP below 140/90 mmHg. For patients with moderate hypertension (140–179/90–109 mmHg), elective care can proceed with stress reduction measures. If BP is 180/110 mmHg or higher, elective dental procedures must be postponed, and the patient referred for urgent medical evaluation. Standard local anaesthetics with 1:80,000 epinephrine are safe up to 2–3 cartridges (maximum 40–60 micrograms epinephrine) in controlled hypertension.
Ischaemic Heart Disease & Myocardial Infarction
Following an acute myocardial infarction (MI), elective invasive dental treatment must be deferred for 6 months due to the high risk of re-infarction, fatal dysrhythmias, and malignant cardiac events. Emergency dental treatment within this 6-month window must be conservative (analgesia, temporary dressings) or performed in a hospital environment with cardiac monitoring. For patients with stable angina or past MI (>6 months), limit local anaesthetic with epinephrine to a maximum of 2 cartridges of 2% lidocaine with 1:80,000 epinephrine (40 micrograms epinephrine total) to minimize cardiovascular strain.
Infective Endocarditis (IE) & NICE Guidance
Historically, patients with structural heart defects received universal antibiotic prophylaxis before invasive dental procedures. However, NICE Clinical Guideline CG64 (updated 2016) explicitly recommends against routine antibiotic prophylaxis for dental procedures in patients at risk of infective endocarditis. Instead, NICE emphasizes:
- Maintaining meticulous oral hygiene to reduce daily low-grade bacteraemias.
- Prompt investigation and management of active dental infections.
- Warning patients about symptoms of endocarditis and the risks of non-medical body piercing or tattooing.
While European Society of Cardiology (ESC) guidelines advocate targeted prophylaxis for extremely high-risk cardiac individuals (e.g. prosthetic heart valves, previous IE, cyanotic congenital heart disease), UK general dental practitioners must adhere to NICE guidance, engaging in multi-disciplinary team discussion with the patient's cardiologist if non-routine prophylaxis is considered.
Anticoagulation & Antiplatelet Management
Management of bleeding risk is guided by SDCEP (Scottish Dental Clinical Effectiveness Programme) Guidance:
- Warfarin (Vitamin K Antagonist): Check International Normalised Ratio (INR) within 24 hours of planned minor oral surgery (or up to 72 hours if INR is consistently stable). If the INR is 4.0 or below, proceed with minor oral surgery (e.g. extractions of up to 3 teeth) without stopping Warfarin. Interrupting Warfarin increases thromboembolic risk (stroke, valve thrombosis) significantly. Local haemostatic measures are mandatory: oxidized regenerated cellulose (Surgicel) placed in the socket, 3-0 absorbable sutures, and 5% tranexamic acid mouthwash or pressure packs.
- Direct Oral Anticoagulants (DOACs): Agents such as Rivaroxaban, Apixaban, Edoxaban (factor Xa inhibitors), and Dabigatran (direct thrombin inhibitor) have short half-lives. For minor oral surgery with low bleeding risk (1–3 extractions), do NOT stop DOAC therapy. Advise the patient to take their dose as normal, but schedule treatment 4–6 hours after the morning dose (or delay the morning dose until after the procedure if taken once daily in the morning).
- Antiplatelet Therapy: Patients on single antiplatelet therapy (Aspirin 75 mg) or dual antiplatelet therapy (DAPT – Aspirin plus Clopidogrel) following coronary stent placement must never discontinue antiplatelet medication for dental extractions. Bleeding can be managed entirely with local haemostatic measures.
Endocrine Dysfunction & Dental Care
Diabetes Mellitus
Diabetic control is assessed using HbA1c (glycated haemoglobin). Target HbA1c for well-controlled diabetes is below 48 mmol/mol (6.5%). Patients with HbA1c above 69 mmol/mol (8.5%) exhibit impaired neutrophil function, delayed wound healing, and heightened susceptibility to periodontal destruction and post-operative infection.
- Appointment Timing: Schedule diabetic patients for short morning appointments shortly after they have consumed their normal breakfast and taken their prescribed insulin or oral hypoglycaemic medication.
- Hypoglycaemia Emergency: Defined as blood glucose below 4.0 mmol/L. Symptoms include diaphoresis, tremors, tachycardia, confusion, and dizziness. If conscious, administer 15–20 g of fast-acting glucose (e.g. 4–5 jelly babies, 150 ml non-diet fruit juice, or 2 tubes of Glucogel). If the patient becomes unconscious, call 999, secure the airway, and administer 1 mg Glucagon intramuscularly (IM).
Adrenal Insufficiency & Steroid Cover
Patients with primary adrenal insufficiency (Addison's Disease) or secondary adrenal suppression due to long-term systemic corticosteroid therapy are unable to mount a physiological cortisol response to surgical stress, risking a life-threatening Adrenal Crisis (severe hypotension, hypovolaemic shock, vomiting, collapse).
- Steroid Cover Cutoff: Supplementary hydrocortisone is required for patients taking systemic corticosteroids equivalent to prednisolone 7.5 mg daily or higher for more than 2 weeks within the preceding 3 months.
- Dosing Protocol: For minor oral surgery under local anaesthesia, instruct the patient to double their regular oral corticosteroid dose 1 hour prior to the appointment. For major oral surgery or procedures under general anaesthesia, administer 100 mg Hydrocortisone IV/IM immediately prior to induction.
Respiratory, Hepatic & Renal Considerations
Asthma
Asthmatic patients must bring their short-acting beta-2 agonist (salbutamol) inhaler (100 micrograms/puff) to every dental appointment. Avoid prescribing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) such as ibuprofen or aspirin, as 10–20% of asthmatics suffer from Aspirin-Exacerbated Respiratory Disease (AERD), where cyclooxygenase-1 inhibition triggers severe, fatal bronchospasm.
Chronic Kidney Disease (CKD)
Patients with end-stage renal disease on haemodialysis require specific management:
- Avoid prescribing nephrotoxic drugs (NSAIDs, tetracyclines).
- Schedule elective dental treatment on the day after a haemodialysis session to allow heparin breakdown and minimize post-operative bleeding.
- Arteriovenous (AV) Fistula Protection: Never measure blood pressure or insert intravenous cannulas in the arm containing an active AV fistula to prevent thrombosis or graft infection.
Hepatic Impairment
Severe liver disease (cirrhosis, hepatitis) impairs the synthesis of vitamin K-dependent clotting factors (Factors II, VII, IX, X), leading to prolonged Prothrombin Time (PT) and bleeding. Additionally, hepatic clearance of amide local anaesthetics (lidocaine, articaine) and paracetamol is reduced. In severe hepatic failure, restrict paracetamol to a maximum dose of 2 g per 24 hours and monitor local anaesthetic dosage carefully.
A 62-year-old patient taking Warfarin for atrial fibrillation requires an extraction of a unsaveable lower molar. Their INR checked 18 hours ago is 3.4. According to SDCEP guidelines, what is the most appropriate management plan?
A patient suffered an acute myocardial infarction (MI) 3 months ago and presents to the dental practice with severe symptomatic irreversible pulpitis in an upper premolar. Which management strategy adheres to UK clinical standards?
During a routine dental filling, a 45-year-old patient with type 1 diabetes becomes pale, diaphoresis is noted, and they respond incoherently to questions. Blood glucose monitoring reveals a level of 2.6 mmol/L, and the patient quickly loses consciousness. What is the immediate drug administration required?